Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 70 | 2026 | 763 | 16.780 |
Why?
|
| Quality of Life | 51 | 2026 | 969 | 9.000 |
Why?
|
| Spirituality | 16 | 2024 | 39 | 4.950 |
Why?
|
| Young Adult | 63 | 2026 | 2651 | 3.730 |
Why?
|
| Adaptation, Psychological | 24 | 2026 | 134 | 3.730 |
Why?
|
| Adolescent | 59 | 2026 | 3516 | 3.100 |
Why?
|
| Psychometrics | 15 | 2022 | 137 | 2.790 |
Why?
|
| Stress, Psychological | 18 | 2026 | 229 | 2.600 |
Why?
|
| Religion and Medicine | 6 | 2016 | 18 | 2.380 |
Why?
|
| Survivors | 17 | 2023 | 174 | 2.350 |
Why?
|
| Adult | 60 | 2026 | 9261 | 2.150 |
Why?
|
| Humans | 105 | 2026 | 32273 | 2.150 |
Why?
|
| Social Support | 10 | 2025 | 181 | 1.970 |
Why?
|
| Depression | 8 | 2026 | 427 | 1.960 |
Why?
|
| Self Efficacy | 4 | 2019 | 74 | 1.790 |
Why?
|
| Resilience, Psychological | 3 | 2024 | 20 | 1.750 |
Why?
|
| Female | 70 | 2026 | 19945 | 1.630 |
Why?
|
| Male | 59 | 2026 | 19438 | 1.570 |
Why?
|
| Health Status | 6 | 2018 | 356 | 1.290 |
Why?
|
| Mental Health | 7 | 2023 | 111 | 1.230 |
Why?
|
| Caregivers | 4 | 2024 | 114 | 1.210 |
Why?
|
| Medical Oncology | 4 | 2023 | 90 | 1.180 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2018 | 31 | 1.150 |
Why?
|
| Emotions | 6 | 2024 | 55 | 1.050 |
Why?
|
| Personal Satisfaction | 5 | 2018 | 29 | 0.900 |
Why?
|
| Decision Support Techniques | 1 | 2026 | 130 | 0.890 |
Why?
|
| Middle Aged | 31 | 2025 | 11840 | 0.860 |
Why?
|
| Telemedicine | 2 | 2023 | 122 | 0.840 |
Why?
|
| Patients | 2 | 2016 | 46 | 0.830 |
Why?
|
| Chronic Disease | 6 | 2023 | 413 | 0.790 |
Why?
|
| Reproducibility of Results | 10 | 2022 | 756 | 0.770 |
Why?
|
| Fatigue | 5 | 2019 | 80 | 0.750 |
Why?
|
| Psychology | 3 | 2019 | 25 | 0.730 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 312 | 0.660 |
Why?
|
| Colorectal Neoplasms | 4 | 2025 | 220 | 0.650 |
Why?
|
| United States | 16 | 2025 | 4069 | 0.630 |
Why?
|
| Biomedical Research | 2 | 2024 | 178 | 0.620 |
Why?
|
| Cognition | 6 | 2015 | 547 | 0.580 |
Why?
|
| Income | 1 | 2019 | 66 | 0.560 |
Why?
|
| Cross-Sectional Studies | 10 | 2026 | 1480 | 0.540 |
Why?
|
| Aged | 19 | 2023 | 10250 | 0.510 |
Why?
|
| Affective Symptoms | 2 | 2015 | 15 | 0.500 |
Why?
|
| Grief | 1 | 2016 | 1 | 0.500 |
Why?
|
| Attitude to Death | 1 | 2016 | 2 | 0.500 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 595 | 0.490 |
Why?
|
| Bereavement | 1 | 2016 | 4 | 0.490 |
Why?
|
| Infertility | 1 | 2016 | 15 | 0.470 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2026 | 545 | 0.470 |
Why?
|
| Religion and Psychology | 3 | 2016 | 5 | 0.460 |
Why?
|
| Guideline Adherence | 1 | 2016 | 109 | 0.450 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 83 | 0.440 |
Why?
|
| Continental Population Groups | 1 | 2016 | 228 | 0.440 |
Why?
|
| Anorexia | 1 | 2014 | 6 | 0.440 |
Why?
|
| Cachexia | 1 | 2014 | 7 | 0.430 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 3893 | 0.430 |
Why?
|
| Breast Neoplasms | 5 | 2026 | 764 | 0.430 |
Why?
|
| Health Status Indicators | 1 | 2014 | 69 | 0.420 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 245 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 395 | 0.410 |
Why?
|
| Ethnic Groups | 1 | 2016 | 450 | 0.410 |
Why?
|
| Factor Analysis, Statistical | 6 | 2019 | 76 | 0.410 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 108 | 0.400 |
Why?
|
| Vomiting | 2 | 2014 | 20 | 0.380 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 42 | 0.380 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 158 | 0.380 |
Why?
|
| Nausea | 2 | 2014 | 50 | 0.380 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 46 | 0.380 |
Why?
|
| Decision Making | 2 | 2026 | 190 | 0.380 |
Why?
|
| Survival Rate | 5 | 2019 | 892 | 0.370 |
Why?
|
| Research Design | 3 | 2023 | 316 | 0.360 |
Why?
|
| Qualitative Research | 2 | 2026 | 180 | 0.360 |
Why?
|
| Social Isolation | 3 | 2024 | 41 | 0.340 |
Why?
|
| Perception | 1 | 2012 | 99 | 0.340 |
Why?
|
| Child | 8 | 2025 | 2431 | 0.330 |
Why?
|
| Health Personnel | 1 | 2012 | 112 | 0.330 |
Why?
|
| Employment | 2 | 2026 | 45 | 0.330 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 422 | 0.320 |
Why?
|
| Ovarian Neoplasms | 3 | 2006 | 84 | 0.300 |
Why?
|
| Socioeconomic Factors | 5 | 2023 | 388 | 0.300 |
Why?
|
| Mental Health Services | 3 | 2024 | 34 | 0.300 |
Why?
|
| Communication | 4 | 2026 | 129 | 0.290 |
Why?
|
| Sexual Behavior | 3 | 2026 | 131 | 0.290 |
Why?
|
| Feasibility Studies | 4 | 2023 | 309 | 0.290 |
Why?
|
| Sexual Partners | 2 | 2026 | 39 | 0.290 |
Why?
|
| Self Concept | 2 | 2023 | 45 | 0.280 |
Why?
|
| Mass Screening | 3 | 2006 | 256 | 0.270 |
Why?
|
| Kidney Neoplasms | 2 | 2023 | 200 | 0.270 |
Why?
|
| Interpersonal Relations | 3 | 2026 | 58 | 0.270 |
Why?
|
| Anxiety | 3 | 2024 | 195 | 0.250 |
Why?
|
| Interviews as Topic | 2 | 2026 | 195 | 0.250 |
Why?
|
| Genital Neoplasms, Female | 1 | 2026 | 30 | 0.240 |
Why?
|
| Behavior | 2 | 2015 | 29 | 0.230 |
Why?
|
| Behavioral Medicine | 2 | 2016 | 6 | 0.220 |
Why?
|
| Attitude | 1 | 2005 | 37 | 0.220 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2022 | 27 | 0.220 |
Why?
|
| Early Detection of Cancer | 1 | 2026 | 101 | 0.220 |
Why?
|
| Cohort Studies | 5 | 2024 | 1840 | 0.220 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2025 | 35 | 0.210 |
Why?
|
| Behavior Therapy | 1 | 2025 | 103 | 0.210 |
Why?
|
| Cancer Care Facilities | 2 | 2017 | 10 | 0.210 |
Why?
|
| Financing, Government | 1 | 2024 | 11 | 0.200 |
Why?
|
| Health Facilities | 1 | 2024 | 14 | 0.200 |
Why?
|
| Research Support as Topic | 1 | 2024 | 32 | 0.200 |
Why?
|
| Empirical Research | 1 | 2023 | 6 | 0.200 |
Why?
|
| Social Conditions | 1 | 2022 | 3 | 0.190 |
Why?
|
| Minority Groups | 1 | 2023 | 81 | 0.190 |
Why?
|
| Prevalence | 3 | 2015 | 955 | 0.190 |
Why?
|
| Sarcoma | 1 | 2023 | 82 | 0.180 |
Why?
|
| Registries | 2 | 2017 | 294 | 0.180 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2025 | 21 | 0.180 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 75 | 0.170 |
Why?
|
| Religion | 3 | 2016 | 28 | 0.170 |
Why?
|
| Health Expenditures | 1 | 2021 | 66 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2021 | 171 | 0.170 |
Why?
|
| Motivation | 1 | 2021 | 121 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 180 | 0.160 |
Why?
|
| Meditation | 1 | 2020 | 28 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3408 | 0.150 |
Why?
|
| Social Change | 1 | 2019 | 2 | 0.150 |
Why?
|
| Psychotherapy | 1 | 2019 | 20 | 0.150 |
Why?
|
| Calibration | 1 | 2019 | 24 | 0.150 |
Why?
|
| Educational Status | 2 | 2026 | 168 | 0.150 |
Why?
|
| Focus Groups | 1 | 2019 | 123 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 106 | 0.140 |
Why?
|
| Comprehension | 1 | 2018 | 18 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2017 | 367 | 0.130 |
Why?
|
| Electronic Health Records | 2 | 2017 | 179 | 0.130 |
Why?
|
| Pilot Projects | 4 | 2025 | 554 | 0.130 |
Why?
|
| Health Behavior | 3 | 2009 | 213 | 0.130 |
Why?
|
| Chicago | 1 | 2016 | 10 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 2238 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 59 | 0.120 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 48 | 0.120 |
Why?
|
| Dementia | 1 | 2019 | 246 | 0.120 |
Why?
|
| Hypertension | 1 | 2023 | 980 | 0.120 |
Why?
|
| Affect | 2 | 2013 | 75 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 24 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 38 | 0.120 |
Why?
|
| Documentation | 1 | 2016 | 39 | 0.120 |
Why?
|
| Spiritual Therapies | 1 | 2015 | 2 | 0.120 |
Why?
|
| Indoles | 1 | 2016 | 65 | 0.120 |
Why?
|
| Students | 2 | 2009 | 174 | 0.110 |
Why?
|
| Pyrroles | 1 | 2016 | 59 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2016 | 86 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1159 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2016 | 77 | 0.110 |
Why?
|
| Prognosis | 1 | 2019 | 1529 | 0.110 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2015 | 37 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 854 | 0.110 |
Why?
|
| Appetite Stimulants | 1 | 2014 | 1 | 0.110 |
Why?
|
| Receptors, Ghrelin | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hydrazines | 1 | 2014 | 4 | 0.110 |
Why?
|
| Palliative Care | 1 | 2015 | 50 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 455 | 0.110 |
Why?
|
| Placebos | 1 | 2014 | 68 | 0.110 |
Why?
|
| Appetite | 1 | 2014 | 23 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2014 | 49 | 0.110 |
Why?
|
| Whole-Body Irradiation | 1 | 2015 | 58 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 113 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2015 | 55 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2017 | 232 | 0.110 |
Why?
|
| Hand Strength | 1 | 2014 | 98 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 656 | 0.100 |
Why?
|
| Sickness Impact Profile | 2 | 2011 | 39 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2023 | 3609 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2015 | 1233 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2014 | 273 | 0.090 |
Why?
|
| Risk Factors | 4 | 2023 | 3933 | 0.090 |
Why?
|
| Mood Disorders | 1 | 2012 | 21 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2014 | 2316 | 0.090 |
Why?
|
| Antiemetics | 1 | 2012 | 5 | 0.090 |
Why?
|
| Pediatrics | 1 | 2013 | 156 | 0.090 |
Why?
|
| Social Desirability | 2 | 2009 | 12 | 0.090 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 5 | 0.090 |
Why?
|
| Weight Loss | 1 | 2014 | 410 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2011 | 72 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2023 | 854 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 183 | 0.080 |
Why?
|
| Kentucky | 1 | 2009 | 15 | 0.070 |
Why?
|
| Universities | 1 | 2009 | 149 | 0.070 |
Why?
|
| Incidence | 2 | 2025 | 1242 | 0.060 |
Why?
|
| Psychological Theory | 1 | 2007 | 6 | 0.060 |
Why?
|
| Parents | 2 | 2021 | 151 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2006 | 393 | 0.060 |
Why?
|
| Information Systems | 2 | 2015 | 9 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 759 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2025 | 31 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 91 | 0.050 |
Why?
|
| Endosonography | 1 | 2004 | 55 | 0.050 |
Why?
|
| Vagina | 1 | 2004 | 61 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 37 | 0.050 |
Why?
|
| Gender Identity | 1 | 2023 | 28 | 0.050 |
Why?
|
| Bisexuality | 1 | 2023 | 32 | 0.050 |
Why?
|
| Data Collection | 1 | 2024 | 171 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 90 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 113 | 0.050 |
Why?
|
| Spouses | 1 | 2022 | 13 | 0.050 |
Why?
|
| Substance-Related Disorders | 2 | 2016 | 140 | 0.040 |
Why?
|
| Genomics | 1 | 2022 | 89 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 167 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 264 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 45 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 1178 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2020 | 35 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 417 | 0.040 |
Why?
|
| Education, Distance | 1 | 2019 | 18 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 129 | 0.040 |
Why?
|
| Exercise | 1 | 2021 | 605 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 221 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 137 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 23 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 55 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 11 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 20 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 18 | 0.030 |
Why?
|
| Internet | 1 | 2016 | 202 | 0.030 |
Why?
|
| American Cancer Society | 1 | 2015 | 3 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 322 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 97 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 78 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 238 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 202 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 38 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 108 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 140 | 0.030 |
Why?
|
| Happiness | 1 | 2013 | 3 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 315 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 207 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 499 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 542 | 0.020 |
Why?
|
| Pain | 1 | 2014 | 302 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 471 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 101 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 8 | 0.010 |
Why?
|
| Ovary | 1 | 2006 | 66 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 155 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 83 | 0.010 |
Why?
|
| Mastectomy | 1 | 2005 | 59 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2005 | 83 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 194 | 0.010 |
Why?
|
| Elder Abuse | 1 | 2004 | 1 | 0.010 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 4 | 0.010 |
Why?
|
| Sick Role | 1 | 2004 | 7 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2006 | 137 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 185 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2004 | 57 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 458 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 8196 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 880 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 1423 | 0.010 |
Why?
|